Liver damage and estrogen therapy of prostatic cancer. Case report.
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002271:Carbutamide / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D004054:Diethylstilbestrol / Q000009:adverse effects*; D004077:Digoxin / Q000627:therapeutic use; D004347:Drug Interactions; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D008055:Lipids / Q000097:blood; D008103:Liver Cirrhosis / Q000139:chemically induced*; D008111:Liver Function Tests; D008297:Male; D005996:Nitroglycerin / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D008055:Lipids; D014280:Triglycerides; D004054:Diethylstilbestrol; D004077:Digoxin; D002271:Carbutamide; D005996:Nitroglycerin